Dr. Jiyeoun Shin at Ultherapy PRIME Advisory Board: Advancing Non-Surgical Ultrasound Lifting in Korea

On January 22, Dr. Jiyeoun Shin, Chief Medical Director, attended the Ultherapy PRIME Advisory Board Meeting (ABM) hosted by Merz.

Advancing Standards for Ultherapy PRIME Treatments

The meeting brought together medical experts to discuss the development of the “Visible Ultrasound Lifting Guide 2.0.”

As patient expectations for non-surgical lifting treatments continue to evolve, the advisory board focused on how to apply the enhanced capabilities of Ultherapy PRIME in a safer, more effective, and more personalized way.

A Patient-Centered Approach to Ultrasound Lifting

Ultherapy PRIME uses real-time ultrasound visualization to help physicians assess the skin and underlying tissue layers before delivering focused ultrasound energy. This technology supports individualized treatment planning based on each patient’s facial anatomy and aesthetic goals.

During the meeting, participating physicians shared clinical perspectives on treatment protocols, safety considerations, and strategies for achieving natural-looking lifting results.

Commitment to Safe, Personalized Care

For international patients seeking non-invasive facial lifting in Korea, choosing a clinic with experienced medical professionals and a commitment to ongoing education is important.

Through participation in expert advisory meetings and clinical discussions, our medical team continues to stay informed about evolving treatment standards and technologies. We remain dedicated to providing carefully planned Ultherapy PRIME treatments designed around each patient’s needs.

Note: This article was translated and published from the original with consent from the author.